Volume | 5,380 |
|
|||||
News | - | ||||||
Day High | 124.427 | Low High |
|||||
Day Low | 123.38 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Sarepta Therapeutics Inc New | SRPT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
123.80 | 123.38 | 124.427 | 123.97 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
92 | 5,380 | $ 123.86 | $ 666,362 | - | 55.25 - 159.89 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:38:35 | 1 | $ 124.3752 | USD |
Sarepta Therapeutics (SRPT) Options Flow Summary
Sarepta Therapeutics Inc New Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
11.64B | 93.86M | - | 1.24B | -535.98M | -5.71 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sarepta Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRPT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 122.25 | 125.4099 | 120.58 | 122.90 | 763,080 | 1.99 | 1.63% |
1 Month | 134.31 | 142.60 | 119.645 | 127.91 | 960,573 | -10.07 | -7.50% |
3 Months | 94.99 | 143.00 | 91.3439 | 119.62 | 1,141,676 | 29.25 | 30.79% |
6 Months | 118.66 | 143.00 | 55.25 | 100.41 | 1,391,657 | 5.58 | 4.70% |
1 Year | 123.89 | 159.89 | 55.25 | 111.59 | 1,331,892 | 0.35 | 0.28% |
3 Years | 85.00 | 159.89 | 55.25 | 100.82 | 1,119,873 | 39.24 | 46.16% |
5 Years | 126.95 | 181.83 | 55.25 | 106.83 | 1,158,936 | -2.71 | -2.13% |
Sarepta Therapeutics Description
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development. |